14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026
STAI vs AEHR: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 20, 2026, Aehr Test Systems (AEHR) is the stronger overall head-to-head candidate over ScanTech AI Systems Inc. (STAI) in the Tradestie Institutional Equity Comparison Engine, winning 5–4 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Balance Sheet & Cash Flow). STAI carries a Unified Composite Score of 51.6/100 (HOLD) at $0.90 (N/M Forward P/E, -773.2% operating margin), whereas AEHR carries 47.8/100 (HOLD) at $39.84 (N/M Forward P/E, -28.3% operating margin).
Composite vs. Pillar Nuance: While STAI currently prints a higher short-term Unified Composite Score (51.6/100 HOLD vs. AEHR 47.8/100 HOLD), AEHR captures the overall institutional head-to-head verdict (5–4 matrix metrics and 4–2 across the 6 pillars) due to superior fundamental profitability (-28.3% vs. -773.2% operating margin) and revenue trajectory (+33.7% vs. +65.5% YoY).
Technical & Structure Timing Caution: STAI trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 32.3); meanwhile AEHR is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 32.3). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Competes within the Semiconductor Equipment & Materials value chain with $1.6B market capitalization and -28.3% operating margin.
OpEx & R&D Reinvestment63.6% of Rev ($32M)
90D Engineering Disclosures0 Published
Mapped Supply-Chain Ecosystem (15 partners):
Texas InstrumentsAnalog DevicesMurata ManufacturingTaiwan Semiconductor Manufacturing Company
Investor FAQ STAI vs AEHR Key Questions & Quantitative Answers
As of Nov 20, 2026, Aehr Test Systems (AEHR) is the stronger overall head-to-head candidate over ScanTech AI Systems Inc. (STAI) in the Tradestie Institutional Equity Comparison Engine, winning 5–4 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Balance Sheet & Cash Flow). STAI carries a Unified Composite Score of 51.6/100 (HOLD) at $0.90 (N/M Forward P/E, -773.2% operating margin), whereas AEHR carries 47.8/100 (HOLD) at $39.84 (N/M Forward P/E, -28.3% operating margin). Composite vs. Pillar Nuance: While STAI currently prints a higher short-term Unified Composite Score (51.6/100 HOLD vs. AEHR 47.8/100 HOLD), AEHR captures the overall institutional head-to-head verdict (5–4 matrix metrics and 4–2 across the 6 pillars) due to superior fundamental profitability (-28.3% vs. -773.2% operating margin) and revenue trajectory (+33.7% vs. +65.5% YoY). Technical & Structure Timing Caution: STAI trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 32.3); meanwhile AEHR is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 32.3). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
STAI leads the Growth & Scale pillar: STAI posts +65.5% YoY revenue growth and +0.0% YoY earnings growth on $1.9M TTM revenue (22.5% gross margin, -773.2% operating margin), compared with AEHR at +33.7% YoY revenue growth and -87.5% YoY earnings growth on $50M TTM revenue (35.3% gross margin, -28.3% operating margin). Across the 8-period historical trajectory (FY2019 to FY2026), STAI cumulative revenue shifted N/A while AEHR shifted +150.0%. In operating R&D and SG&A reinvestment, STAI deploys N/A (0 90-day corporate R&D disclosures) versus 63.6% of Rev ($32M) (0 disclosures) for AEHR.
AEHR screens cheaper on headline valuation multiples. STAI trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 16.4x EV/Revenue (unreported FCF margin), whereas AEHR trades at N/M Forward P/E, 66.2x Trailing P/E, 0.48x PEG, and 29.5x EV/Revenue (-13.6% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against STAI (33.7% ROE) versus AEHR (-4.2% ROE) capital efficiency.
In options market volatility and institutional positioning, STAI carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-3.45β · 168% Vol realized risk). By comparison, AEHR carries 193.3% implied volatility (34th %ile, Balanced (25th–60th %ile)), a 0.94x (Balanced) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a BREAKDOWN options structure phase (5.42β · 166% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.